Affiliation:
1. SRM Institute of Science and Technology, Chennai, India
2. National Institute of Fashion Technology, New Delhi, India
3. K.S.R. College of Engineering, India
4. SRM Institute of Science and Technology, India
Abstract
This chapter explores the transformative impact of industrial automation on drug discovery, specifically within the context of the emerging paradigm of Industry 5.0. The convergence of advanced technologies, including robotics, artificial intelligence, and the internet of things (IoT), is reshaping the landscape of pharmaceutical manufacturing, leading to the development of smart manufacturing processes tailored for the intricacies of drug discovery. Industry 5.0, characterized by the integration of cyber-physical systems with human-centric approaches, provides a framework for the evolution of pharmaceutical manufacturing towards increased automation and intelligence. In drug discovery, industrial automation streamlines processes such as compound synthesis, high-throughput screening, and quality control, resulting in enhanced efficiency, precision, and reproducibility. Robotic systems, equipped with AI-driven algorithms, play a pivotal role in automating labor-intensive tasks, reducing human error, and expediting the drug development pipeline.
Reference25 articles.
1. An Useful Survey on Supervised Machine Learning Algorithms: Comparisons and Classifications
2. Use of artificial intelligence in industrial automation: A review.;R.Agrawal;International Journal of Advanced Research in Computer Science,2018
3. A review of artificial intelligence in industrial automation.;M.Akbari;International Journal of Automation and Computing,2020
4. Artificial intelligence and internet of things: A systematic review of their industrial applications.;M.Al-Emran;Computers & Electrical Engineering,2021
5. Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification.;P. J.Ballester;Journal of the Royal Society, Interface,2015